The Notch Pathway in Antigen Design
The Notch Pathway in Antigen Design
批准号:
10575892
负责人:
David M Allman
金额:
$26.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-18 至 2025-07-31
关键词:
AffinityAntibodiesAntibody AffinityAntibody ResponseAntibody titer measurementAntigensB Cell ProliferationB cell repertoireB-Cell Antigen ReceptorB-LymphocytesBindingCellsClonal ExpansionClone CellsComplementComplement 3dComplement 3d ReceptorsComplexDataEpitopesEventExcisionFrequenciesGlycoproteinsHIVHIV AntibodiesHIV envelope proteinHumoral ImmunitiesImmunizationIn VitroInfectionLabelLigandsLigationMembraneMemoryMemory B-LymphocyteMicrobeMusMutatePathway interactionsPhysiologic pulsePlasma CellsPlayPolysaccharidesProtocols documentationPublishingReceptor ActivationReceptor SignalingRoleSecondary toSerologySerumSpecificityTestingVaccine DesignVariantVirusWorkdesignexperienceglycosylationimmunogenicimmunogenicityimprovedin vivoinsightmosaicnanoparticleneutralizing antibodynotch proteinnovel vaccinesreceptorresponsestemtoolvaccination strategyvaccine strategyvaccine-induced immunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
There is an urgent need to develop new vaccination strategies that induce antibodies that
target relevant epitopes on complex microbes. Moreover, approaches that allow control of
the number and fine specificity repertoire of responding naïve or memory B cells would
fuel new vaccine designs for a variety of mutating viruses. This project centers on the
hypothesis that co-engagement of the B cell receptor (BCR) for antigen with the Notch2
receptor will amplify responses by naïve and memory B cells. This hypothesis builds on
preliminary data showing that BCR+Notch2 co-stimulation increases both number of B
cells that respond and the number of proliferative events experienced by these cells. To
test our hypothesis, we will generate unique mosaic nanoparticles based on immunogenic
and sub-immunogenic variants of the HIV envelop (Env) antigen. We will answer the
following questions: 1) Does BCR+Notch2 co-engagement prime naïve clones to target
native-like Env variants?, and 2) Does BCR+Notch2 co-engagement on memory B cells
increase their contribution to GC and PC pools? These studies will provide unique and
needed insights into the potential exploitation of BCR signaling thresholds in emerging
vaccine design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
-
批准号:10637251
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10441466
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10240081
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10215534
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10443660
-
项目类别:
-
资助金额:$68.88万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10652461
-
项目类别:
-
资助金额:$65.66万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Plasma Cell Priming
-
批准号:9403332
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2017
-
负责人:David M Allman
-
依托单位:
Epigenetic Control of Plasma Cell Differentiation
-
批准号:9105812
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9111850
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9315100
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:8772548
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8387887
-
项目类别:
-
资助金额:$38.93万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8680129
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8508182
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:9096003
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8868901
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:8066726
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:7983146
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7812028
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7268827
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
海外基金